Yanan Gu

424 total citations
27 papers, 300 citations indexed

About

Yanan Gu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yanan Gu has authored 27 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Yanan Gu's work include Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Aldose Reductase and Taurine (2 papers). Yanan Gu is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Aldose Reductase and Taurine (2 papers). Yanan Gu collaborates with scholars based in China, United Kingdom and United States. Yanan Gu's co-authors include Kaijie Wu, Shiqi Wu, Xinyang Wang, Shan Cheng, Dalin He, Wen G. Jiang, Ke Hui, Yangyang Yue, Chengcheng Hao and Jer‐Tsong Hsieh and has published in prestigious journals such as Journal of Clinical Oncology, Small and RSC Advances.

In The Last Decade

Yanan Gu

26 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanan Gu China 11 177 95 79 58 53 27 300
Lokman Varışlı Türkiye 11 261 1.5× 100 1.1× 88 1.1× 94 1.6× 43 0.8× 28 410
Lin‐wen Wu China 12 225 1.3× 82 0.9× 69 0.9× 88 1.5× 22 0.4× 18 381
Megumi Morimoto Japan 13 176 1.0× 63 0.7× 86 1.1× 47 0.8× 29 0.5× 18 366
Dae Hwa Choi South Korea 10 257 1.5× 96 1.0× 43 0.5× 84 1.4× 41 0.8× 13 368
Qiaohong Qin China 11 248 1.4× 190 2.0× 61 0.8× 44 0.8× 41 0.8× 23 416
Hsi-Wen Yeh United States 6 222 1.3× 94 1.0× 54 0.7× 57 1.0× 24 0.5× 7 332
Tatsuhiko Shigeto Japan 12 265 1.5× 122 1.3× 76 1.0× 77 1.3× 35 0.7× 24 474
Yang-ling Li China 11 229 1.3× 102 1.1× 77 1.0× 82 1.4× 30 0.6× 22 350
Eun-Jung Lim South Korea 10 173 1.0× 82 0.9× 44 0.6× 105 1.8× 33 0.6× 11 329
Veronica Henderson United States 10 307 1.7× 182 1.9× 99 1.3× 157 2.7× 50 0.9× 15 479

Countries citing papers authored by Yanan Gu

Since Specialization
Citations

This map shows the geographic impact of Yanan Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Gu more than expected).

Fields of papers citing papers by Yanan Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Gu. The network helps show where Yanan Gu may publish in the future.

Co-authorship network of co-authors of Yanan Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Gu. A scholar is included among the top collaborators of Yanan Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Gu. Yanan Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, An, Yanan Gu, Hui‐Wen Yang, et al.. (2025). Glycyrrhiza flavonoids improves hyperglycemia inT2DM mice by microbial-gut-liver axis. Journal of Functional Foods. 127. 106741–106741. 1 indexed citations
2.
Wu, Wei, Hao Song, Yanan Gu, et al.. (2025). Carbon Dot Nanozymes with Ferrous Ion‐Chelating and Antioxidative Activity Inhibiting Ferroptosis to Alleviate Renal Ischemia‐Reperfusion Injury. Small. 21(16). e2407372–e2407372. 7 indexed citations
3.
Gu, Yanan, Shiqi Wu, Tianjie Liu, et al.. (2024). CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression. Cell Death and Disease. 15(1). 79–79. 29 indexed citations
4.
Hu, Yaguang, et al.. (2024). Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma. Molecular and Cellular Probes. 75. 101959–101959. 1 indexed citations
5.
Gu, Yanan, et al.. (2023). Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer. Urologic Oncology Seminars and Original Investigations. 41(8). 354.e1–354.e9. 5 indexed citations
6.
Gu, Yanan, Qi Liu, Qian Chen, et al.. (2023). MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma. BMC Cancer. 23(1). 1267–1267. 3 indexed citations
7.
Wang, Qi, Shiqi Wu, Yanan Gu, et al.. (2022). RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis. Cell Death Discovery. 8(1). 275–275. 10 indexed citations
8.
Gu, Yanan, Shiqi Wu, Bing Guan, et al.. (2022). DAB2IP regulates intratumoral testosterone synthesis and CRPC tumor growth by ETS1/AKR1C3 signaling. Cellular Signalling. 95. 110336–110336. 6 indexed citations
9.
Wu, Shiqi, Yangyang Yue, Yanan Gu, et al.. (2021). MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling. Cellular Signalling. 84. 110015–110015. 13 indexed citations
10.
Liu, Li, Yinliang Qi, Dake Huang, et al.. (2021). Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma. International Journal of Oncology. 59(2).
11.
Yue, Yangyang, Ke Hui, Shiqi Wu, et al.. (2020). MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma. Cell Death and Disease. 11(5). 336–336. 22 indexed citations
12.
Hui, Ke, Shiqi Wu, Yangyang Yue, et al.. (2018). RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer. Cellular Signalling. 48. 38–44. 20 indexed citations
13.
Wang, Bin, Yanan Gu, Ke Hui, et al.. (2018). AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. Urologic Oncology Seminars and Original Investigations. 36(10). 472.e11–472.e20. 41 indexed citations
14.
Hui, Ke, Yangyang Yue, Shiqi Wu, et al.. (2018). The expression and function of RASAL2 in renal cell carcinoma angiogenesis. Cell Death and Disease. 9(9). 881–881. 19 indexed citations
15.
Liu, Ying, Ping‐Hui Sun, Gang Chen, et al.. (2017). Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. International Journal of Oncology. 50(5). 1491–1500. 13 indexed citations
16.
Yang, Feng‐Lian, Yanan Gu, Zehang Zhao, et al.. (2017). NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial–Mesenchymal Transition. Anticancer Research. 37(8). 4405–4414. 7 indexed citations
17.
Du, Guifang, Yanan Gu, Chengcheng Hao, et al.. (2016). The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. Oncotarget. 7(20). 29440–29453. 15 indexed citations
18.
Dou, Qingli, Yuanyuan Wei, Yanan Gu, & Hong Zheng. (2016). Investigating the Therapeutic Effects of N-Acetylcysteine Decorated Poly(L-lactic acid) Nanoparticles on Transfusion Induced Acute Lung Injury. Journal of Biomaterials and Tissue Engineering. 7(1). 69–76. 8 indexed citations
19.
Hao, Chengcheng, Zhiyan Wang, Yanan Gu, Wen G. Jiang, & Shan Cheng. (2016). Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis. BioMed Research International. 2016. 1–8. 19 indexed citations
20.
Qiu, Feng, Yanan Gu, Tingting Wang, et al.. (2015). Quantification and pharmacokinetics of crizotinib in rats by liquid chromatography–tandem mass spectrometry. Biomedical Chromatography. 30(6). 962–968. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lokman Varışlı Breakdown of academic impact, for papers by Lin‐wen Wu Breakdown of academic impact, for papers by Megumi Morimoto Breakdown of academic impact, for papers by Dae Hwa Choi Breakdown of academic impact, for papers by Qiaohong Qin Breakdown of academic impact, for papers by Hsi-Wen Yeh Breakdown of academic impact, for papers by Tatsuhiko Shigeto Breakdown of academic impact, for papers by Yang-ling Li Breakdown of academic impact, for papers by Eun-Jung Lim Breakdown of academic impact, for papers by Veronica Henderson
Rankless by CCL
2026